Wang Luojia

BBI Life Sciences Corporation is an investment holding company principally engaged in the development, manufacture, and sales of various life science products used in scientific research, and the provision of life science-related services. These products and services offered by the Company are used in the studies of life sciences including animal and plant, disease, medical diagnosis, drug development, food, and agriculture industry. The Company has four business segments: deoxyribonucleic acid (DNA) synthesis products, genetic engineering services, life science research consumables as well as protein and antibody-related products and services. The principal markets of the Company include the People's Republic of China (the PRC), North America, South America, Europe, and Africa.